172 related articles for article (PubMed ID: 34708234)
21. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
22. Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease.
Sheedfar F; Sung MM; Aparicio-Vergara M; Kloosterhuis NJ; Miquilena-Colina ME; Vargas-Castrillón J; Febbraio M; Jacobs RL; de Bruin A; Vinciguerra M; García-Monzón C; Hofker MH; Dyck JR; Koonen DP
Aging (Albany NY); 2014 Apr; 6(4):281-95. PubMed ID: 24751397
[TBL] [Abstract][Full Text] [Related]
23. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
[TBL] [Abstract][Full Text] [Related]
24. Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis.
Lee J; Song JH; Park JH; Chung MY; Lee SH; Jeon SB; Park SH; Hwang JT; Choi HK
Exp Mol Med; 2023 Jan; 55(1):143-157. PubMed ID: 36609599
[TBL] [Abstract][Full Text] [Related]
25. Ferulic Acid and P-Coumaric Acid Synergistically Attenuate Non-Alcoholic Fatty Liver Disease through HDAC1/PPARG-Mediated Free Fatty Acid Uptake.
Cui K; Zhang L; La X; Wu H; Yang R; Li H; Li Z
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499624
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia.
Cui A; Fan H; Zhang Y; Zhang Y; Niu D; Liu S; Liu Q; Ma W; Shen Z; Shen L; Liu Y; Zhang H; Xue Y; Cui Y; Wang Q; Xiao X; Fang F; Yang J; Cui Q; Chang Y
J Clin Invest; 2019 Apr; 129(6):2266-2278. PubMed ID: 31033478
[TBL] [Abstract][Full Text] [Related]
27. Hepatic Krüppel-like factor 14 regulates lipid metabolism in nonalcoholic steatohepatitis mice.
Chen X; Shi W; Xie Y; Wang Y; Yao Q; Ke H; Xu X; Liu H; Liu P; Zhou X
FASEB J; 2023 Aug; 37(8):e23070. PubMed ID: 37389939
[TBL] [Abstract][Full Text] [Related]
28. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice.
Chen M; Bai M; Yi Y; Lu S; Luo J; Li P; Zhang H; Jiang H; Zhou H
Toxicol Lett; 2022 Jun; 363():1-10. PubMed ID: 35589016
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36.
Shen C; Chen JH; Oh HR; Park JH
FEBS Lett; 2021 Oct; 595(19):2493-2503. PubMed ID: 34536973
[TBL] [Abstract][Full Text] [Related]
31. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
[TBL] [Abstract][Full Text] [Related]
32. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
33. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142
[TBL] [Abstract][Full Text] [Related]
34. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
[TBL] [Abstract][Full Text] [Related]
36. The effects of intermittent hypoxia on hepatic expression of fatty acid translocase CD36 in lean and diet-induced obese mice.
Ji Y; Liang Y; Chu PH; Ge M; Yeung SC; Ip MSM; Mak JCW
Biomed J; 2023 Oct; 46(5):100566. PubMed ID: 36244649
[TBL] [Abstract][Full Text] [Related]
37. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing.
Zeng H; Qin H; Liao M; Zheng E; Luo X; Xiao A; Li Y; Chen L; Wei L; Zhao L; Ruan XZ; Yang P; Chen Y
Mol Metab; 2022 Mar; 57():101428. PubMed ID: 34974159
[TBL] [Abstract][Full Text] [Related]
38. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
[TBL] [Abstract][Full Text] [Related]
39. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.
Yang Q; Shu F; Gong J; Ding P; Cheng R; Li J; Tong R; Ding L; Sun H; Huang W; Wang Z; Yang L
J Ethnopharmacol; 2020 Jun; 255():112556. PubMed ID: 31926984
[TBL] [Abstract][Full Text] [Related]
40. Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy.
Díaz P; Harris J; Rosario FJ; Powell TL; Jansson T
Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(12):R1569-77. PubMed ID: 26491104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]